Comparison of different delivery systems of DNA vaccination for the induction of protection against tuberculosis in mice and guinea pigs


Autoria(s): Paula, Lúcia de; Silva, Célio L; Carlos, Daniela ; Matias-Peres, Camila ; Sorgi, Carlos A; Soares, Edson G; Souza, Patrícia RM; Bladés, Carlos RZ; Galleti, Fábio CS; Bonato, Vânia LD; Gonçalves, Eduardo DC; Silva, Érika VG; Faccioli, Lúcia H
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

26/08/2013

26/08/2013

01/01/2007

Resumo

The great challenges for researchers working in the field of vaccinology are optimizing DNA vaccines for use in humans or large animals and creating effective single-dose vaccines using appropriated controlled delivery systems. Plasmid DNA encoding the heat-shock protein 65 (hsp65) (DNAhsp65) has been shown to induce protective and therapeutic immune responses in a murine model of tuberculosis (TB). Despite the success of naked DNAhsp65-based vaccine to protect mice against TB, it requires multiple doses of high amounts of DNA for effective immunization. In order to optimize this DNA vaccine and simplify the vaccination schedule, we coencapsulated DNAhsp65 and the adjuvant trehalose dimycolate (TDM) into biodegradable poly (DL-lactide-co-glycolide) (PLGA) microspheres for a single dose administration. Moreover, a single-shot prime-boost vaccine formulation based on a mixture of two different PLGA microspheres, presenting faster and slower release of, respectively, DNAhsp65 and the recombinant hsp65 protein was also developed. These formulations were tested in mice as well as in guinea pigs by comparison with the efficacy and toxicity induced by the naked DNA preparation or BCG. The single-shot prime-boost formulation clearly presented good efficacy and diminished lung pathology in both mice and guinea pigs.

We thank Izaira T. Brandão and Ana S. Mason for technical assistance. Fundação de Amparo a Pesquisa do Estado de São Paulo (FAPESP), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and Instituto do Milênio REDE TB supported this study.

We thank Izaira T. Brandão and Ana S. Mason for technical assistance. Fundação de Amparo a Pesquisa do Estado de São Paulo (FAPESP), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and Instituto do Milênio REDE TB supported this study.

Identificador

1479-0556

http://www.producao.usp.br/handle/BDPI/33031

10.1186/1479-0556-5-2

http://www.gvt-journal.com/content/5/1/2

Idioma(s)

eng

Relação

Genetic Vaccines and Therapy

Direitos

openAccess

de Paula et al; licensee BioMed Central Ltd. - This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Tipo

article

original article